Penbrook Management LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 30 filers reported holding EXAGEN INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Penbrook Management LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2023$177,652
-17.2%
73,410
-0.8%
0.13%
-16.7%
Q2 2023$214,629
+19.3%
74,0100.0%0.16%
+13.0%
Q1 2023$179,844
+1.2%
74,0100.0%0.14%
-8.6%
Q4 2022$177,624
-24.7%
74,010
-14.9%
0.15%
-25.6%
Q3 2022$236,000
-53.4%
87,000
-1.2%
0.20%
-49.1%
Q2 2022$506,000
-28.8%
88,100
-0.6%
0.40%
-13.4%
Q1 2022$711,000
-31.0%
88,6000.0%0.46%
-25.8%
Q4 2021$1,030,000
-13.7%
88,600
+1.0%
0.62%
-16.2%
Q3 2021$1,193,00087,7500.74%
Other shareholders
EXAGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
HighTower Trust Company, N.A. 2,683,578$231,056,00024.22%
Stonepine Capital Management, LLC 1,260,387$7,235,0003.37%
PERKINS CAPITAL MANAGEMENT INC 236,975$1,360,0001.41%
COWEN AND COMPANY, LLC 1,355,414$7,780,0000.75%
Penbrook Management LLC 88,100$506,0000.40%
RTW INVESTMENTS, LP 1,025,002$5,884,0000.15%
PLATINUM INVESTMENT MANAGEMENT LTD 400,000$2,296,0000.09%
Nantahala Capital Management 156,135$896,0000.04%
First Bank & Trust 23,176$133,0000.04%
WASATCH ADVISORS LP 1,011,945$5,809,0000.04%
View complete list of EXAGEN INC shareholders